drugset / Trial / NCT04024254

A Study of Serum Folate Levels in Patients Treated With Olaparib

NCT04024254

Phase 4 Completed 10 enrolled Rush University Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.

Timeline

Start
2020-07-21
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject folic acid Other / unclassified 1 mg Oral